The stock of USANA Health Sciences, Inc. (NYSE:USNA) hit a new 52-week high and has $216.88 target or 49.00% above today’s $145.56 share price. The 7 months bullish chart indicates low risk for the $1.75 billion company. The 1-year high was reported on Oct, 7 by Barchart.com. If the $216.88 price target is reached, the company will be worth $857.50 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 87,136 shares traded hands or 16.55% up from the average. USANA Health Sciences, Inc. (NYSE:USNA) has risen 23.57% since March 4, 2016 and is uptrending. It has outperformed by 15.53% the S&P500.
Analysts await USANA Health Sciences, Inc. (NYSE:USNA) to report earnings on November, 1. They expect $2.11 EPS, up 9.90% or $0.19 from last year’s $1.92 per share. USNA’s profit will be $25.37M for 17.25 P/E if the $2.11 EPS becomes a reality. After $2.07 actual EPS reported by USANA Health Sciences, Inc. for the previous quarter, Wall Street now forecasts 1.93% EPS growth.
USANA Health Sciences, Inc. (NYSE:USNA) Ratings Coverage
Out of 3 analysts covering USANA Health Science (NYSE:USNA), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. USANA Health Science has been the topic of 5 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The rating was downgraded by DA Davidson on Thursday, August 6 to “Neutral”. The company was upgraded on Wednesday, August 5 by Pivotal Research. DA Davidson upgraded the shares of USNA in a report on Wednesday, September 16 to “Buy” rating. The stock has “Buy” rating given by Sidoti on Friday, October 16.
According to Zacks Investment Research, “USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company’s three primary product lines consist of nutritional, personal care and weight management products. The company’s products are distributed primarily through a network marketing system.”
Insitutional Activity: The institutional sentiment increased to 0.9 in Q2 2016. Its up 0.48, from 0.42 in 2016Q1. The ratio improved, as 11 funds sold all USANA Health Sciences, Inc. shares owned while 51 reduced positions. 21 funds bought stakes while 35 increased positions. They now own 4.92 million shares or 4.65% less from 5.16 million shares in 2016Q1.
Ahl Partners Limited Liability Partnership has invested 0.18% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA). Northern Corp holds 76,548 shares or 0% of its portfolio. Babson Mngmt Limited holds 0.01% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA) for 2,800 shares. The Texas-based Wfg Advsr Limited Partnership has invested 0% in USANA Health Sciences, Inc. (NYSE:USNA). Alps has invested 0% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA). Blackrock Ltd Limited Liability Company holds 0% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA) for 22,007 shares. D E Shaw Incorporated, a New York-based fund reported 50,656 shares. Clark Gp accumulated 2,600 shares or 0.02% of the stock. New York State Common Retirement Fund has 12,997 shares for 0% of their US portfolio. Moreover, State Board Of Administration Of Florida Retirement Sys has 0% invested in USANA Health Sciences, Inc. (NYSE:USNA) for 2,149 shares. Da Davidson & Co accumulated 1,160 shares or 0% of the stock. Deere last reported 11,164 shares in the company. First Advsrs L P last reported 0% of its portfolio in the stock. Usa Portformulas accumulated 0.32% or 10,349 shares. The California-based Schwab Charles Invest Management has invested 0% in USANA Health Sciences, Inc. (NYSE:USNA).
Insider Transactions: Since April 13, 2016, the stock had 0 buys, and 24 selling transactions for $24.26 million net activity. On Wednesday, May 11 Gull Global Ltd sold $1.23 million worth of the stock or 10,000 shares. WENTZ MYRON W also sold $1.23 million worth of USANA Health Sciences, Inc. (NYSE:USNA) on Wednesday, June 8. Jones Paul A. had sold 5,067 shares worth $701,780 on Tuesday, August 30. Bramble James also sold $1.23M worth of USANA Health Sciences, Inc. (NYSE:USNA) on Monday, August 15. Another trade for 1,058 shares valued at $148,120 was made by Woo Deborah on Thursday, September 8. FULLER GILBERT A sold $117,739 worth of USANA Health Sciences, Inc. (NYSE:USNA) on Monday, August 1. Brown Jim also sold $1.20 million worth of USANA Health Sciences, Inc. (NYSE:USNA) on Monday, August 15.
More news for USANA Health Sciences, Inc. (NYSE:USNA) were recently published by: Businesswire.com, which released: “USANA Health Sciences’ China Subsidiary, BabyCare Ltd., Receives Approval for …” on May 12, 2016. Prnewswire.com‘s article titled: “USANA Brand Ambassador Monica Puig Captures Historic Gold, Leads Team USANA To …” and published on August 29, 2016 is yet another important article.
USNA Company Profile
USANA Health Sciences, Inc., incorporated on July 20, 1992, develops and makes science nutritional and personal care products. The Firm has activities in approximately 20 markets across the world. The Firm operates as a direct selling firm in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions, which include Southeast Asia Pacific, Greater China and North Asia. Southeast Asia Pacific comprises Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand and Indonesia. Greater China includes Hong Kong, Taiwan and China. North Asia comprises Japan and South Korea. The Company’s product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. The Company’s USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately 13 months age. The USANA Nutritionals Essentials products include USANA Essentials and HealthPak 100. The Company’s Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. These products support needs, such as cardiovascular health, skeletal/structural health and digestive health, and are intended to be used in conjunction with the Essentials. The Optimizers products include Proflavanol, CoQuinone 30 and BiOmega-3.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.